A detailed history of Act Capital Management, LLC transactions in Marker Therapeutics, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 354,400 shares of MRKR stock, worth $1.1 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
354,400
Previous 354,400 -0.0%
Holding current value
$1.1 Million
Previous $117,000 11.97%
% of portfolio
0.18%
Previous 0.16%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$0.95 - $1.72 $80,750 - $146,200
-85,000 Reduced 19.34%
354,400 $337,000
Q3 2021

Nov 16, 2021

BUY
$1.68 - $2.88 $32,592 - $55,872
19,400 Added 4.62%
439,400 $743,000
Q2 2021

Aug 16, 2021

BUY
$1.88 - $3.56 $789,600 - $1.5 Million
420,000 New
420,000 $1.17 Million

Others Institutions Holding MRKR

About Marker Therapeutics, Inc.


  • Ticker MRKR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,599,200
  • Market Cap $259M
  • Description
  • Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...
More about MRKR
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.